LON:GSK - GlaxoSmithKline Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 1,571 -10.00 (-0.63 %)
(As of 02/18/2019 03:06 PM ET)
Previous CloseGBX 1,581
Today's RangeGBX 1,564 - GBX 1,580
52-Week RangeGBX 1,235.20 - GBX 1,724.50
Volume3.89 million shs
Average Volume9.12 million shs
Market Capitalization£77.26 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of vaccines, over-the-counter medicines, and health-related consumer products worldwide. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, dermatology, rare diseases, immuno-inflammation, and HIV, as well as vaccines. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories primarily under the Otrivin, Panadol, Fenistil, Lamisil, Breathe Right, Stiefel, Excedrin, Physiogel, Polident, parodontax, Poligrip, Sensodyne, Theraflu, and Voltaren brand names. The company offers its consumer healthcare products in the form of tablets, caplets, infant syrup drops, syrups, topical gels, nasal sprays, effervescents, lozenges, gum and trans-dermal patches, malted drinks and foods, and topical creams and non-medicated patches, as well as toothpastes, toothbrushes, mouth rinses, medicated mouthwashes, gels and sprays, denture adhesives, and denture cleansers. It has a discovery collaboration agreement with Kymera Therapeutics LLC; a collaboration agreement with InSysBio LLC to develop quantitative systems pharmacology model of asthma; and a strategic collaboration with NeuroMetrix, Inc. to develop and market Quell technology. GlaxoSmithKline plc also has a joint research collaboration with Fimbrion Therapeutics Inc. to develop a small molecule candidate for the treatment and prevention of urinary tract infections. The company was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone+44-20-80475000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees98,462
Outstanding Shares4,918,060,032
Market Cap£77.26 billion
OptionableOptionable

GlaxoSmithKline (LON:GSK) Frequently Asked Questions

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline announced a dividend on Wednesday, February 6th. Shareholders of record on Thursday, February 21st will be given a dividend of GBX 23 per share on Thursday, April 11th. This represents a dividend yield of 1.49%. The ex-dividend date is Thursday, February 21st. This is an increase from GlaxoSmithKline's previous dividend of $19.00. The official announcement can be accessed at this link. View GlaxoSmithKline's Dividend History.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (LON:GSK) posted its quarterly earnings results on Wednesday, April, 25th. The company reported $24.60 EPS for the quarter, topping analysts' consensus estimates of $24.30 by $0.30. View GlaxoSmithKline's Earnings History.

What price target have analysts set for GSK?

18 Wall Street analysts have issued 12-month price objectives for GlaxoSmithKline's stock. Their forecasts range from GBX 41.74 to GBX 1,900. On average, they expect GlaxoSmithKline's stock price to reach GBX 1,520.93 in the next year. This suggests that the stock has a possible downside of 3.2%. View Analyst Price Targets for GlaxoSmithKline.

What is the consensus analysts' recommendation for GlaxoSmithKline?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 2 sell ratings, 10 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for GlaxoSmithKline.

Has GlaxoSmithKline been receiving favorable news coverage?

News coverage about GSK stock has trended somewhat positive on Monday, according to InfoTrie. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. GlaxoSmithKline earned a coverage optimism score of 1.6 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the next several days.

Who are some of GlaxoSmithKline's key competitors?

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the folowing people:
  • Ms. Emma Walmsley, CEO & Director (Age 49)
  • Mr. Simon P. Dingemans, CFO & Exec. Director (Age 55)
  • Mr. Jack Bailey, Pres of US Pharmaceuticals
  • Ms. Karenann K. Terrell, Chief Digital & Technology Officer (Age 58)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 56)

How do I buy shares of GlaxoSmithKline?

Shares of GSK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,571.

How big of a company is GlaxoSmithKline?

GlaxoSmithKline has a market capitalization of £7,726.27 billion. GlaxoSmithKline employs 98,462 workers across the globe.

What is GlaxoSmithKline's official website?

The official website for GlaxoSmithKline is http://www.gsk.com/.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000.


MarketBeat Community Rating for GlaxoSmithKline (LON GSK)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  874 (Vote Outperform)
Underperform Votes:  1,414 (Vote Underperform)
Total Votes:  2,288
MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Vote "Outperform" if you believe GSK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GSK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel